Health-related quality of life in high-grade glioma patients: a prospective single-center study
- PMID: 22160582
- DOI: 10.1007/s00520-011-1340-4
Health-related quality of life in high-grade glioma patients: a prospective single-center study
Abstract
Purpose: In this single center study, we aimed to assess quality of life and cognitive and emotional distress in patients treated for high-grade glioma.
Methods and materials: A hundred and eighteen patients with high-grade glioma were prospectively enrolled. We assessed HRQoL at baseline (after surgery before radiotherapy), at the end of radiotherapy and during follow-up (every 3 months for the first 2 years and every 6 months between 2 and 5 years) using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire 30 (EORTC-C30), Brain Cancer Module-20 (BN-20), Minimental State Examination (MMSE) and Hospital Anxiety and Depression Scale (HADS). Baseline scores, and first 18-month follow-up period scores were included to statistical analysis.
Results: Sixty-five (55%) patients had progressive tumor. Global score, physical, role and emotional function, insomnia (p for each <0.001) and appetite loss (p: 0.008) scores of EORTC-C30 significantly related to disease progression. According to BN-20 seizure and leg weakness (p < 0.001), drowsiness and bladder control (p: 0.002), motor dysfunction (p: 0.001), future uncertainty (p: 0.04), visual disorder (p: 0.008) and communication deficit (p: 0.006) symptoms significantly related to disease progression. There were significant decrements in orientation, attention and calculation and language scores (p values were 0.017, 0.005 and 0.003, respectively) of MMSE. The baseline and follow-up anxiety and depression scores did not differ significantly.
Conclusion: We conclude that there were many changes in patients with high-grade glioma during the course of the disease and most of them were related to disease progression.
Similar articles
-
Prospective assessment of health-related quality of life in patients with low-grade glioma: a single-center experience.Support Care Cancer. 2012 Aug;20(8):1859-68. doi: 10.1007/s00520-011-1288-4. Epub 2011 Oct 8. Support Care Cancer. 2012. PMID: 21979904 Clinical Trial.
-
Health-related quality of life in glioma patients in China.BMC Cancer. 2010 Jun 18;10:305. doi: 10.1186/1471-2407-10-305. BMC Cancer. 2010. PMID: 20565883 Free PMC article.
-
Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice.J Neurooncol. 2009 Dec;95(3):413-419. doi: 10.1007/s11060-009-9939-8. Epub 2009 Jun 23. J Neurooncol. 2009. PMID: 19548070
-
Impact of brain tumour treatment on quality of life.J Neurol. 2002 Aug;249(8):955-60. doi: 10.1007/s00415-002-0839-5. J Neurol. 2002. PMID: 12195437 Review.
-
Health-related quality of life in patients with high-grade glioma.Neuro Oncol. 2009 Feb;11(1):41-50. doi: 10.1215/15228517-2008-050. Epub 2008 Jul 15. Neuro Oncol. 2009. PMID: 18628405 Free PMC article. Review.
Cited by
-
Occurrence and predictors of the fatigue in high-grade glioma patients.Neurol Sci. 2015 Aug;36(8):1363-9. doi: 10.1007/s10072-015-2111-7. Epub 2015 Feb 20. Neurol Sci. 2015. PMID: 25698127
-
Health-related quality of life in patients with high-grade gliomas: a quantitative longitudinal study.J Neurooncol. 2015 Sep;124(2):185-95. doi: 10.1007/s11060-015-1821-2. Epub 2015 May 31. J Neurooncol. 2015. PMID: 26026860
-
Progression-free survival versus post-progression survival and overall survival in WHO grade 2 gliomas.Acta Oncol. 2024 Oct 20;63:798-804. doi: 10.2340/1651-226X.2024.40845. Acta Oncol. 2024. PMID: 39428639 Free PMC article.
-
Impact of neurosurgical enhanced recovery after surgery (ERAS) program on health-related quality of life in glioma patients: a secondary analysis of a randomized controlled trial.J Neurooncol. 2020 Jul;148(3):555-567. doi: 10.1007/s11060-020-03548-y. Epub 2020 Jun 6. J Neurooncol. 2020. PMID: 32506368 Clinical Trial.
-
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients.Neurooncol Pract. 2022 Jun 22;9(6):526-535. doi: 10.1093/nop/npac049. eCollection 2022 Dec. Neurooncol Pract. 2022. PMID: 36388423 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical